The company announced that Jim Clemmer has informed the Board of Directors of his intention to retire from the company upon the appointment of a successor, which is anticipated to occur during fiscal 2027. The Board has established a search committee to conduct a comprehensive search, which will be assisted by a leading executive search firm, to identify the company’s next CEO. Until his successor is appointed, Clemmer will continue as President and CEO, leading and overseeing the company’s strategic and financial initiatives with a focus on revenue growth and profitability.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ANGO:
- Options Volatility and Implied Earnings Moves This Week, January 06 – January 08, 2026
- ANGO Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Midday Fly By: Tesla reports deliveries, Trump delays furniture tariff hike
- Buy Rating for AngioDynamics Driven by New Clinical Trial and Product Synergy
- AngioDynamics Announces Board Election at Annual Meeting